| 摘要 |
FIELD: medicine, ophthalmology, pharmacy. SUBSTANCE: ophthalmic drops contain mixture of 0.1 wt. -% of glycoseaminoglycans isolated from human placenta as an active substance, 2 wt. -% of polyvinylpyrrolidone, and physiological solution, the balance. Proposed ophthalmic drops provide effective healing and reduced time of treatment. EFFECT: enhanced effectiveness of ophthalmic drops. 1 tbl |
